Success Stories: An Instructor in the Field of Biomedical Science from Hong Kong is Helped by NAILG’s Team to Get NIW Approval Without RFE

Client’s Testimonial:

“NAILG provided professional and expedient service when putting together my NIW petition. They were always quick when answering my questions provided invaluable advice and guidance through the petitioning process.”

On August 23^rd, 2022, we received another EB-2 NIW (National Interest Waiver) approval for an Instructor in the Field of Biomedical Science (Approval Notice).

General Field: Biomedical Science

Position at the Time of Case Filing: Instructor

Country of Origin: Hong Kong

State of Residence at the Time of Filing: Illinois

Approval Notice Date: August 23^rd, 2022

Processing Time: 14 months, 26 days

Case Summary:

An expert in the field of biomedical science, our client from Hong Kong was working as an instructor in the field when he came to us seeking help with his NIW (National Interest Waiver) petition. He wanted to continue his research on how the immune system behaves in skin cancers and identify new mutations that drive their formation to develop new therapies against them.

Our team of experts could easily see that his research had great substantial merit and national importance. This was necessary proof for NIW approval shown by the fact that his work was relevant to cancer research as well as autoimmune and inflammatory bowel disease treatment, medical technology, and public health worldwide. This was why one of his 4 recommenders said the following:

“In sum, [the client] is a highly pragmatic, highly influential researcher compelling innovation in the field of biomedical science. As made evident here, his findings are beneficial for the medical and healthcare sectors and the fight against cancer.”

On the other hand, our team collected other relevant data for his case such as his publication and citation count, his major funding sources, etc. We were thus able to show that his research has resulted in 13 peer-reviewed journal articles (4 of them first-authored) and these papers have been published in no fewer than 10 highly ranked peer-reviewed journals. At the same time, these publications have been cited a total of 298 times according to Google Scholar.

We also showed that he had received at least 5 major financial aid from institutes such as the National Institutes of Health, the National Institute of Diabetes and Digestive and Kidney Diseases, etc. Therefore, another favorable recommender said:

“Breastcancer.org estimates that about 1 in 8 women will develop invasive breast cancer throughout her lifetime. These statistics are alarming, necessitating the work of researchers like [the client], who research the mechanisms responsible for cancer progression, including the molecular mediators of breast cancer metastasis… Hence, the research conducted by [the client] has tremendous national benefit as it not only helps in advancing the field of biomedical science but also leads to the betterment of public health in the United States and across the world.”

We are grateful to the USCIS for his NIW approval, and we take this opportunity to thank our team of experts and once again congratulate our client on this victory. Also, we wish our client success in all his future endeavors.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.